{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T00:05:15Z","timestamp":1759536315466,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2001,10,1]],"date-time":"2001-10-01T00:00:00Z","timestamp":1001894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2001,10]]},"DOI":"10.1053\/ajkd.2001.27413","type":"journal-article","created":{"date-parts":[[2008,3,17]],"date-time":"2008-03-17T23:33:20Z","timestamp":1205796800000},"page":"S95-S99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"S","title":["Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure"],"prefix":"10.1053","volume":"38","author":[{"given":"Yoshihiro","family":"Takamitsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ajkd.2001.27413_BIB1","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1161\/01.CIR.94.11.2743","article-title":"Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations","volume":"94","author":"Robinson","year":"1996","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2001.27413_BIB2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: A perspective for 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1053\/ajkd.2001.27413_BIB3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0021-9150(95)05730-7","article-title":"Homocysteine-mediated endothelial cell toxicity and its amelioration","volume":"122","author":"Blundell","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1053\/ajkd.2001.27413_BIB4","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1161\/01.CIR.95.5.1119","article-title":"Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans","volume":"95","author":"Tawakol","year":"1997","journal-title":"Circulation"},{"key":"10.1053\/ajkd.2001.27413_BIB5","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/ndt\/12.12.2623","article-title":"Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis","volume":"12","author":"Joannides","year":"1997","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 2","key":"10.1053\/ajkd.2001.27413_BIB6","first-page":"S14","article-title":"Endothelium-dependent vasodilation and distensibility of large arteries in chronic haemodialysis patients","volume":"12","author":"van Guldener","year":"1997","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2001.27413_BIB7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1172\/JCI118771","article-title":"Vascular dysfunction in monkeys with diet-induced hyperhomocys(e)inemia","volume":"98","author":"Lenz","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2001.27413_BIB8","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1161\/01.ATV.17.10.1947","article-title":"Homocys(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial","volume":"17","author":"Evans","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1053\/ajkd.2001.27413_BIB9","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI112442","article-title":"Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine","volume":"77","author":"Starkebaum","year":"1986","journal-title":"J Clin Invest"},{"key":"10.1053\/ajkd.2001.27413_BIB10","doi-asserted-by":"crossref","first-page":"17012","DOI":"10.1074\/jbc.272.27.17012","article-title":"Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase","volume":"272","author":"Upchurch","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1053\/ajkd.2001.27413_BIB11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000057428","article-title":"Homocysteine, a new crucial element in the pathogenesis of uremic cardiovascular complications","volume":"25","author":"Perna","year":"1999","journal-title":"Miner Electrolyte Metab"},{"key":"10.1053\/ajkd.2001.27413_BIB12","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1046\/j.1523-1755.2000.00936.x","article-title":"Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease","volume":"57","author":"Pannier","year":"2000","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2001.27413_BIB13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0735-1097(90)90584-C","article-title":"Large coronary arteries in human are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis","volume":"16","author":"Nabel","year":"1990","journal-title":"J Am Coll Cardiol"},{"key":"10.1053\/ajkd.2001.27413_BIB14","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/ki.1994.336","article-title":"Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients","volume":"46","author":"Gris","year":"1994","journal-title":"Kidney Int"},{"key":"10.1053\/ajkd.2001.27413_BIB15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9343(00)00695-1","article-title":"Does renal failure cause an atherosclerotic milieu in patients with end-stage renal disease?","volume":"110","author":"Kennedy","year":"2001","journal-title":"Am J Med"},{"key":"10.1053\/ajkd.2001.27413_BIB16","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/BF00429099","article-title":"Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus","volume":"35","author":"McVeigh","year":"1992","journal-title":"Diabetologia"},{"key":"10.1053\/ajkd.2001.27413_BIB17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ndt\/13.1.106","article-title":"No change in impaired endothelial function after long-term folic acid therapy of hyperhomocysteinaemia in haemodialysis patients","volume":"13","author":"van Guldener","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2001.27413_BIB18","first-page":"282","article-title":"Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: No change in endothelial function after long-term therapy","volume":"18","author":"van Guldener","year":"1998","journal-title":"Perit Dial Int"},{"key":"10.1053\/ajkd.2001.27413_BIB19","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/ndt\/14.8.1934","article-title":"Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: Is homocyst(e)ine the missing link?","volume":"14","author":"Kunz","year":"1999","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/ajkd.2001.27413_BIB20","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.CIR.102.8.871","article-title":"Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?","volume":"102","author":"Thambyrajah","year":"2000","journal-title":"Circulation"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638601606413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638601606413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:23:59Z","timestamp":1759454639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638601606413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["S0272638601606413"],"URL":"https:\/\/doi.org\/10.1053\/ajkd.2001.27413","relation":{},"ISSN":["0272-6386"],"issn-type":[{"type":"print","value":"0272-6386"}],"subject":[],"published":{"date-parts":[[2001,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/ajkd.2001.27413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2001 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}